|
GB0123549D0
|
|
Processes
|
|
GB0122399D0
|
|
Dosage forms
|
|
GB0121677D0
|
|
Dosage
|
|
GB0121036D0
|
|
Nose lung inhaler for antiviral prophylaxis or therapy
|
|
GB0119007D0
|
|
Polymer converter
|
|
GB0118366D0
|
|
Multiple-therapy drug delivery
|
|
GB0117197D0
|
|
Mixer-reactor droplet and vapour dispenser
|
|
GB0117196D0
|
|
Space sprays
|
|
GB0116085D0
|
|
Battery driven electrostatic sprays
|
|
GB0116088D0
|
|
Controlled comminution and delivery of liquids using piezoelectricity
|
|
GB0115227D0
|
|
Manufacturing dissolvable dosage forms
|
|
GB0114844D0
|
|
Formulation delivery
|
|
GB0111721D0
|
|
Compositions
|
|
GB0108340D0
|
|
Consumable products
|
|
GB0107226D0
|
|
Formulations
|
|
GB0107225D0
|
|
Consumable products
|
|
GB0021300D0
|
|
Nose lung inhaler for antiviral prophylaxis or therapy
|
|
GB0019085D0
|
|
Polymer converter
|
|
GB0018687D0
|
|
Multiple therapy drug delivery
|
|
GB0017404D0
|
|
Space sprays
|
